Restoration of Meibomian Gland Functionality with Novel Mesenchymal Stem Cell-Derived Product “Derived-Multiple Allogeneic Proteins Paracrine Signaling (d-MAPPS)”: A Case Report

Data publikacji: 20 cze 2023

Zakres stron: 169 - 174

Otrzymano: 24 lut 2020

Przyjęty: 17 mar 2020

DOI: https://doi.org/10.2478/sjecr-2020-0059

Słowa kluczowe

Meibomian gland dysfunction, therapy, mesenchymal stem cells, d-MAPPS

© 2023 Carl Randall Harrell et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.